NCT03233711 2026-03-18
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
9 trialsNCT06896370 2026-02-25
An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
Fudan University
Recruiting
NCT06192719 2026-02-18
EULAT
Centre Paul Strauss
Recruiting
NCT07405476 2026-02-12
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Phase 2 Not yet recruiting
NCT07400354 2026-02-10
The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota
Fudan University
Recruiting
NCT07177742 2026-02-06
Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
Shanghai Tongji Hospital, Tongji University School of Medicine
Recruiting
NCT07391007 2026-02-05
Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases
Fudan University
Not yet recruiting
NCT06958328 2026-02-02
LAP100
NRG Oncology
Phase 3 Recruiting
NCT03533582 2025-12-22
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Children's Oncology Group
Phase 3 Active not recruiting